ghk-cu topical peptide Organic Copper Moisturizer – Firming & Smoothing and no unnecessary fillers Ghk-cu Peptide for Anti-Aging &

Published Phase 2 clinical trial data used doses of 1mg, 4mg, 8mg, and 12mg administered weekly via subcutaneous injection

BPC 157 has been extensively studied in various clinical trials for its regenerative effects on various bodily tissues, including muscles, tendons, ligaments, and the gastrointestinal tract and may modulate vascular endothelial growth factor (VEGF) expression, promoting healing by enhancing the formation and growth factor of new blood vessels

Because it lacks long-term human clinical trials, the full long-term side effect profile is unknown

REDEFINE 2 Trial Type 2 Diabetes with Obesity The companion REDEFINE 2 trial, also published in 2025, enrolled 1,206 adults with type 2 diabetes and obesity or overweight, demonstrating the combinations efficacy in this more metabolically compromised population: Mean weight loss of 13.7% compared to 3.4% with placebo over 68 weeks 73.5% achieved hemoglobin A1c of 6.5% or less compared to 15.9% with placebo Greater proportions reaching multiple weight thresholds including 5%, 10%, 15%, and 20% reduction Significant glycemic improvement with mean A1c reduction demonstrating disease modification potential Favorable metabolic profile changes including improvements in blood pressure and lipids These findings established that the combination maintains substantial efficacy even in patients with the metabolic dysfunction of established type 2 diabetes, a population often showing reduced response to weight-loss interventions